Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04684719 · ClinicalTrials.gov registry record · Phase 3

Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial

A Phase 3 study of Traumatic Injury and Hemorrhagic Shock, sponsored by Jason Sperry.

Completed
Registry status
Phase 3
Development phase
1,020
Enrollment target
10
Study locations

NCT04684719 is a Phase 3 study of Traumatic Injury and Hemorrhagic Shock that has completed, run by Jason Sperry. The registered enrollment target is 1,020 participants, above the 294-participant average among 7 other Traumatic Injury trials with a reported enrollment target (247% higher). The trial reports 10 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04684719, a Phase 3 study of Traumatic Injury and Hemorrhagic Shock, has completed, sponsored by Jason Sperry.

COMPLETED
Registry status
Phase 3
Development phase
1,020 participants
Enrollment target
10
Study locations

Study Summary

Open label, multi-center, pre-hospital randomized trial utilizing 10 level-1 trauma centers designed to determine the efficacy and safety of low titer whole blood resuscitation as compared to standard of care resuscitation in patients at risk of hemorrhagic shock and to appropriately characterize the hemostatic competency of whole blood relative to its age.

Conditions Studied

Traumatic Injury Hemorrhagic Shock

Interventions

  • BIOLOGICAL low titer whole blood
  • BIOLOGICAL Standard Care

Study Locations (10)

Ohio

  • University of Cincinatti - Cincinnati
  • Metrohealth Systems - Cleveland

Tennessee

  • University of Tennessee Medical Center - Knoxville
  • Vanderbilt University Medical Center - Nashville

Alabama

  • University of Alabama at Birmingham - Birmingham

Kentucky

  • University of Louisville - Louisville

Mississippi

  • University of Mississippi Medical Center (UMMC) - Jackson

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Texas

  • University of Texas Health Science Center at Houston - Houston

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 1,020 participants
Start Date 2022-04-19
Est. Completion 2025-08-12
Phase Phase 3

Sponsor

Jason Sperry

10 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04684719

The ClinicalTrials.gov registry entry for NCT04684719 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,020 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 294-participant average among 7 other Traumatic Injury trials with a reported enrollment target (247% higher). The listed sponsor is Jason Sperry, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Traumatic Injury appearing as the primary indexed condition, and to 2 interventions - of which low titer whole blood is the first listed.

NCT04684719 reports 10 study locations spanning 8 distinct geographic areas - top geographies include Ohio, Tennessee, Alabama.

Frequently Asked Questions

What is clinical trial NCT04684719 about?

NCT04684719 is a clinical study titled "Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial". Open label, multi-center, pre-hospital randomized trial utilizing 10 level-1 trauma centers designed to determine the efficacy and safety of low titer whole blood resuscitation as compared to standard of care resuscitation in patients at risk of hemorrhagic shock and to appropriately characterize th...

What is the current status of trial NCT04684719?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,020 participants. The study started on 2022-04-19. Estimated completion is 2025-08-12.

What conditions does trial NCT04684719 study?

This clinical trial studies the following conditions: Traumatic Injury, Hemorrhagic Shock.

What interventions are being tested in trial NCT04684719?

The interventions under investigation include: low titer whole blood (BIOLOGICAL), Standard Care (BIOLOGICAL).

Who is sponsoring clinical trial NCT04684719?

This trial is sponsored by Jason Sperry, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04684719 being conducted?

This trial has 10 study locations across Alabama, Kentucky, Mississippi, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Traumatic Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Traumatic Injury

All registered trials for this condition

Hemorrhagic Shock

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.